Hansa Biopharma — August 2024
-
Automatisk teknisk analys. Medellång sikt, 20 aug 2024:
Hansa Biopharma (HNSA) - Teknisk analys - Stockholmsb�rsen - Investtech
Teknisk analys Hansa Biopharma (HNSA).
(www.investtech.com)
-
Hansa Biopharma Announces Departure of Chief
Commercial Officer, Matthew Shaulis https://mb.cision.com/Public/1219/4028110/bc9b46375205ee0e.pdf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind